Skip to main content

MIT Corporate Relations

MIT Corporate Relations
MIT Logo
  • Events
  • STEX25
  • Startups
  • opportunities
  • MIT ILP
  • Sign-In
  • Register Your Startup
  • Search
STEX Home
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
User Menu and Search
  • Sign-In
  • Register Your Startup
STEX Home
Toggle menu
  • Sign-in
  • Register your startup
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP

Search Results


Filter Results
Staff

Filter Results

Narrow your search results
  • News (0)
  • Videos (21)
  • Events (0)
  • Startup Opportunities (5)
  • Startups
  • Founders
Please sign-in to see the full search results
33 search results found
  • DUST Identity

    Newton, MA
    Technology
    DUST -- the Diamond Uncloneable Security Tag -- is a proprietary technology which utilizes nanodiamonds to create an unclonable identity layer on any object. An optical scanner and cloud-based infrastructure provides an interface to the object identity and provenance. DUST ensures that trusted data... More
    Keywords:
    #supplychain #security #nanotech #cybersecurity #IoT #blockchain #counterfeit #trackandtrace
    DUST Identity logo
  • Collins-Synthetic Biology

    Synthetic Biology Workshop 2017 - Academic Keynote - Innovations in Synthetic Biology

    September 12, 2017 | Startup Exchange Video | Duration: 16:38

    James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.

  • Asimov, Inc.

    Cambridge, Massachusetts
    Biotechnology
    Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More
    Asimov-color
  • Lightning-Synthetic Biology

    Synthetic Biology Workshop 2017 - Lightning Talks

    September 12, 2017 | Startup Exchange Video | Duration: 42:25

    Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.

  • Cellino Biotech, Inc.

    Cambridge, MA
    Biotechnology
    Cellino has built the first platform that enables precise control over iPS cell fate in their natural environment. Their proprietary delivery technology, NanoLaze, delivers synthetic biology tools to control the sequence of genes being turned on and off inside a cell. This offers precise, “digital”... More
    Cellino_color
  • Aditya Khosla, Cofounder & CTO, PathAI

    PathAI

    November 15, 2018 | Startup Exchange Video | Duration: 21:45

    PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.

  • Cracking Cancer 2.0 - Panel Discussion

    Cracking Cancer 2.0 - Panel Discussion

    December 7, 2017 | Startup Exchange Video | Duration: 47:30

    Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.

  • Stratagen Bio

    Cambridge, MA
    Biotechnology
    Tumor hypoxia is characterized by extremely low levels of oxygen (<15.2 mmHg/2% O2). It occurs in fifty percent1 of all tumors and is a well-established negative prognostic indicator. Poor outcomes are seen in patients with hypoxic tumors in cancers including breast, cervical, head and neck, soft... More
    Keywords:
    Oxygen Sensing, Magnetic Resonance Imaging, Image-Guided Therapies, personalized medicine
    StratagenBio Logo color
  • Paula Hammond

    Cracking Cancer 2.0 - Cancer Innovation - The Long View

    December 7, 2017 | Startup Exchange Video | Duration: 15:22

    Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio

  • Synthetic Biology Workshop 2017 - Panel Discussion

    Synthetic Biology Workshop 2017 - Panel Discussion

    September 12, 2017 | Startup Exchange Video | Duration: 47:6

    Synthetic Biology Workshop 2017 - Panel Discussion

Pagination

  • of 4
  • 1
  • 2
  • 3
  • 4
  • Next page
  • Events
    • Corporates
    • Event Videos
    • Startups
  • STEX25
    • Featured
    • Videos
  • Startups
    • Search
    • News
  • opportunities
  • MIT ILP
  • Twitter
  • YouTube
  • LinkedIn
Home

1 Main Street
12th Floor, E90-1201
Cambridge, MA 02142


Accessibility

Privacy Policy

617-253-2691
startupexchange@mit.edu

Office of Corporate Relations